|Products||Sunrise Hyperion LTK System|
|Company||Sunrise Technologies International, Inc.|
|Item||Sunrise Hyperion LTK System|
|Features|| LTK treats mild farsightness and also provides a means of treating presbyopia (age-induced farsightedness). The procedure aims to allow patients to see near objects without glasses. For the FDA trial that led to approval of the procedure, at 12 months, 85.0% of the eyes were corrected to 20/40 or better and 37.4% were corrected to 20/20 or better visual acuity without spectacles or contact lenses. Due to the noninvasive and quick nature of the surgery, there was a lower incidence of complications for LTK than with LASIK, with less than 1% adverse events.|
Other benefits unique to LTK are extremely fast procedure time (approximately 3 seconds of laser per eye), having the procedure done in the physician's office the ability to have both eyes done at once, and immediate positive results.
|Description||Sunrise Technologies has developed laser thermal keratoplasty (LTK). This procedure was FDA approved on June 30, 2000 for the temporary reduction of hyperopia from +0.75 to +2.50 diopters for patients 40 years and older with up to 0.75 diopters of astigmatism and refractive stability for the previous 6 months. Unlike most refractive surgery, LTK is not performed in an operating suite but in an ordinary exam room. It involves the strategic placement of 16 laser spots onto the peripheral cornea. In LTK, the eye is numbed with anesthetic drops and held open with an eyelid holder. The tear film is allowed to dry for 3 minutes before the laser is applied. The laser application itself takes less than 3 seconds per eye. The treatment thermally contracts the tissue, causing the central cornea to steepen. A bandage soft contact lens is usually placed on the eye until the following day. They eye may have some irritation for the first few days.|
|Info|| Sunrise Technologies International, Inc.|